Araştırma Makalesi
BibTex RIS Kaynak Göster

Leukocyte and Platelet Rich Fibrin: Characteristics and Clinical Applications in Dentistry

Yıl 2014, Cilt: 48 Sayı: 2, 73 - 83, 27.06.2014

Öz

Several platelet concentrates are avaliable in different techniques; however, their biological contents vary from one to another. Leukocyte platelet-rich fibrin (L-PRF) belongs to a new generation of platelet concentrates, with simplified processing and without biochemical blood handling. Although plateletderived growth factors play an important role in biology of PRF, fibrin organization and the leukocyte content are other two key variables. Due to the growth factor and cell content, L-PRF has a positive effect on natural wound healing. Frequency of L-PRF usage in dentistry is increasing, because of its positive effects on soft tissue and bone healing.

Kaynakça

  • Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost 2006;4(5):932-9.
  • Carlson NE, Roach RB Jr. Platelet rich plasma: clinical applications in dentistry. J Am Dent Assoc 2002;133(10):1383-6. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(6):638-46.
  • Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet cancentrates: from pure plateletrich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27(3):158-67.
  • Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14(4):529-35. Tamimi FM, Montalvo S, Tresguerres I, Blanco Jerez L. A comparative study of two methods for obtaining plateletrich plasma. J Oral Maxillofac Surg 2007;65(6):1084-93.
  • Clausen, C, Hermund NU, Donatsky O, Nielsen H, Osther K. Homologous activated platelets stimulate differentiation and proliferation of primary human bone cells. Cells Tissues Organs 2006;184(2):68–75.
  • Krasna, M, Domanović D, Tomsic A, Svajger U, Jeras M. Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerol Alp Panonica Adriat 2007;16(3):105–10.
  • Anitua, E, Andía I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, Nurden P, Nurden AT. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23(2):281–6.
  • Akeda, K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ, Lenz ME, Sah RL, Masuda K. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006;14(12):1272–80.
  • Okuda, K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, Wolff LF, Yoshie H. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 2003;74(6):849–57.
  • Lucarelli, E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003;24(18):3095–100.
  • Cenni, E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 2005;76(3):323–8.
  • Slapnicka, J, Fassmann A, Strasak L, Augustin P, Vanek J. Effects of activated and nonactivated platelet-rich plasma on proliferation of human osteoblasts in vitro. J Oral Maxillofac Surg 2008;66(2):297–301.
  • Graziani, F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006;17(2):212–9.
  • Choukroun J, Adda F, Schoffler C, Vervelle A. Une opprtumnité en paroimplantologie: Le PRF. Implantodontie 2001;42:55-62.
  • Dohan D, Donsimoni J-M, Navarro G, Gaultier F. Platelet concentrates, part II: associated biology. Implantodontie 2003;12:17-25.
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part I: technological concepts and and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):37-44. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part II: platelet related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e45-50.
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e51-5.
  • Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e56-60.
  • Diss A, Dohan DM, Mouhyi J, Mahler P. Osteotome sinus flor elevation using Choukroun’s platelet-rich fibrin as grfting material: one year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105(5):572-9.
  • Choukroun JI, Braccini F, Diss A, Giordano G, Doglioli P, Dohan DM. Influence of plateler rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: a new opportunity in facial lipostructure (Coleman’s technique) and tympanoplasty? Rev Laryngol Otol Rhinol (Bord) 2007;128(1-2):27-32.
  • Braccini F, Dohan DM. The relevance of Choukroun’s plateler rich fibrin (PRF) during facial esthetic lipostructure (Coleman’s technique): preliminary results. Rev Laryngol Otol Rhinol(Bord) 2007;128(4):255-60.
  • Dohan DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol 2010;81(4):546-55.
  • Dohan DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27(1):63-9.
  • Cieslik-Bielecka A, Gazdzik TS, Bielecki TM, Cieslik T. Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Raidol Endod 2007;103(3):303-5.
  • El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 2007;78(4):661-9. van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis, Ann N Y Acad Sci 2001;936:426-37.
  • Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998;273(13):7554-9.
  • Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003;196(2):245-50.
  • Chang IC, Tsai CH, Chang YC. Plateletrich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res A 2010;95(1):327-32.
  • Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB. Choukroun’s Platelet-rich Fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependant way, Arch Oral Biol 2010;55(3):185-94.
  • Tsai CH, Shen SY, Zhao JH, Chang YC. Platelet-rich fibrin modulates cell proliferation of human periodontally related cells in vitro. J Dent Sci 2009;4:130-5. Tunalı M, Özdemir H, Küçükodacı Z, Akman S, Fıratlı E. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate. Br J Oral Maxillofac Surg 2013;51(5):438
  • Kim BJ, Kwon TK, Baek HS, Hwang DS, Kim CH, Chung IK, Jeong JS, Shin SH. A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and plateletrich-fibrin-mixed tricalcium phosphate in rabbits. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113(5):583-92.
  • Lee JW, Kim SG, Kim JY, Lee YC, Choi JY, Dragos R, Rotaru H. Restoration of a peri-implant defect by platelet-rich fibrin. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113(4):459-63.
  • Knapen M, Gheldof D, Drion P, Layrolle P, Rompen E, Lambert F. Effect of leukocyte- and platelet-rich fibrin (L-PRF) in bıne regeneration: a study in rabbits. Clin Implant Dent Relat Res 2013; doi: 1111/cid.12146. [Epub ahead of print]
  • Rudagi KB, Rudagi B. One-step apexification in ımmature tooth using grey mineral trioxide aggregate as an apical barrier and autologus platelet-rich fibrin membrane as an ınternal matrix. J Conserv Dent 2012;15(2):196-9.
  • Ruga E, Gallesio C, Boffano P. Plateletrich fibrin and piezoelectric surgery: a safe technique for the prevention of periodontal complications in third molar surgery. J Craniofac Surg 2011;22(5):1951-5.
  • Hoaglin DR, Lines GK. Prevention of localized osteitis in mandibular thirdmolar sites using platelet-rich fibrin. Int J Dent 2013; doi: 10.1155/2013/875380. Epub 2013 Apr 4.
  • Inchingolo F, Tatullo M, Marrelli M, Inchingolo AM, Scacco S, Inchingolo AD, Dipalma G, Vermesan D, Abbinante A, Cagiano R. Trial with platelet-rich fibrin and bio-oss used as grafting materials in the treatment of severe maxillar bone atrophy: clinical and radiological evaluations. Eur Rev Med Pharmacol Sci 2010;14(12):1075-84.
  • Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer DR, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using choukroun’s platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol 2009;80(12):2056-64.
  • Tajima N, Ohba S, Sawase T, Asahina I. Evaluation of sinus florr augmentation with simultaneous placement using platelet-rich fibrin as sole grafting material. Int J Oral Maxillofac Implants 2013;28(1):77-83.
  • Lekovic V, Milinkovic I, Aleksic Z, Jankovic S, Stankovic P, Kenney EB, Camargo PM. Platelet-rich fibrin and bovine porous bone mineral vs. plateletrich fibrin in the treatment of ıntrabony periodontal defects. J Periodontal Res 2012;47(4):409-17.
  • Bansal C, Bharti V. Evaluation of efficacy of autologous platelet-rich fibrin with demineralized-freeze dried bone allogaft in the treatment of periodontal intrabony defetcs. J Indian Soc Periodontol 2013;17(3):361-6.
  • Pradeep AR, Sharma A. Autologous platelet rich fibrin in the treatment of mandibular degree II furcation defects: a randomized clinical trial. J Periodontol 2011;82(10):1396-403.
  • Peck MT, Marnewick J, Stephen L. Alveolar ridge preservation using leukocyte and platelet-rich fibrin: a report of a case. Case Rep Dent 2011;345048.doi: 1155/2011/345048. Epub 2011 Jul 3. Hauser F, Gaydarov N, Badoud I, Vazquez L, Bernard JP, Ammann P. Clinical and histological evaluation of postextraction platelet-rich fibrin socket filling: a prospective randomized controlled study. Implant Dent 2013;22(3):295-303.
  • Del Corso M, Mazor Z, Rutkowski JL, Dohan Ehrenfest DM. The use of leukocyte- and platelet-rich fibrin during immediate postextractive implantation and loading for the esthetic replacement of a fractured maxillary central incisor. J Oral Implantol 2012;38(2):181-7.
  • Aroca S, Keglevich T, Nikolidakis D, Gera I, Nagy K, Azzi R, Etienne D. Treatment of class III multiple gingival recessions: a randomized-clinical trial. J Clin Periodontol 2010;37(1):88–97.
  • Jankovic S, Aleksic Z, Milinkovic I, Dimitrijevic B. The coronally advanced flap in combination with platelet-rich fibrin (PRF) and enamel matrix derivative in the treatment of gingival recession: a comparative study. Eur J Esthet Dent 2010;5(3):260-73.
  • Jankovic S, Aleksic Z, Klokkevold P, Lekovic V, Dimitrijevic B, Kenney EB, Camargo P. Use of platelet-rich fibrin membrane following treatment of gingival recession: a randomized clinical trial. Int J Periodontics Restorative Dent 2012;32(2):e41-50.
  • Eren G, Atilla G. Platelet-rich fibrin in the treatment of bilateral gingival recessions. Clinical Advances in Periodontics 2012;2(3):154-60.
  • Eren G. Kök yüzeyi örtülmesinde trombositten zengin fibrin ve bağ dokusu grefti uygulamalarının etkinliklerinin karşılaştırılması. Doktora Tezi, Ege Üniversitesi Sağlık Bilimleri Enstitüsü Periodontoloji Anabilim Dalı, 2012. Yazışma Adresi: Gülnihal EREN Ege Üniversitesi
  • Diş Hekimliği Fakültesi Periodontoloji A.D. 35100 Bornova-İzmir, Türkiye Tel: 0232 3881105 e-posta: gulnihal_karasu@hotmail.com

LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI

Yıl 2014, Cilt: 48 Sayı: 2, 73 - 83, 27.06.2014

Öz

Günümüzde çeşitli tekniklerle elde edilen farklı trombosit konsantrasyonları bulunmaktadır. Benzer
isimlerle anılsa bile, bu konsantrasyonların biyolojik içerikleri farklıdır. Lökosit ve trombositten zengin
fibrin (L-TZF), kan kaynaklı trombosit konsantrasyonları arasında en son geliştirilenidir. Herhangi bir
antikoagülan ajana gerek duyulmadan hazırlanan L-TZF’nin eldesi kolaydır. L-TZF’nin biyolojisinde
her ne kadar trombosit kaynaklı büyüme faktörleri önemli bir rol oynasa da, fibrin organizasyonu ve
lökosit içeriği de diğer iki anahtar değişkenini oluşturur. Bu nedenle L-TZF, içeriğinde bulunan büyüme
faktörleri ve hücreler sayesinde doğal yara iyileşmesini olumlu yönde etkiler. Yumuşak doku ve kemik
iyileşmesi üzerindeki olumlu özellikleri nedeniyle günümüzde L-TZF’nin diş hekimliği alanında kullanım
sıklığı giderek artmaktadır.

Kaynakça

  • Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost 2006;4(5):932-9.
  • Carlson NE, Roach RB Jr. Platelet rich plasma: clinical applications in dentistry. J Am Dent Assoc 2002;133(10):1383-6. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(6):638-46.
  • Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet cancentrates: from pure plateletrich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27(3):158-67.
  • Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14(4):529-35. Tamimi FM, Montalvo S, Tresguerres I, Blanco Jerez L. A comparative study of two methods for obtaining plateletrich plasma. J Oral Maxillofac Surg 2007;65(6):1084-93.
  • Clausen, C, Hermund NU, Donatsky O, Nielsen H, Osther K. Homologous activated platelets stimulate differentiation and proliferation of primary human bone cells. Cells Tissues Organs 2006;184(2):68–75.
  • Krasna, M, Domanović D, Tomsic A, Svajger U, Jeras M. Platelet gel stimulates proliferation of human dermal fibroblasts in vitro. Acta Dermatovenerol Alp Panonica Adriat 2007;16(3):105–10.
  • Anitua, E, Andía I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, Nurden P, Nurden AT. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23(2):281–6.
  • Akeda, K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ, Lenz ME, Sah RL, Masuda K. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006;14(12):1272–80.
  • Okuda, K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, Wolff LF, Yoshie H. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 2003;74(6):849–57.
  • Lucarelli, E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003;24(18):3095–100.
  • Cenni, E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 2005;76(3):323–8.
  • Slapnicka, J, Fassmann A, Strasak L, Augustin P, Vanek J. Effects of activated and nonactivated platelet-rich plasma on proliferation of human osteoblasts in vitro. J Oral Maxillofac Surg 2008;66(2):297–301.
  • Graziani, F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006;17(2):212–9.
  • Choukroun J, Adda F, Schoffler C, Vervelle A. Une opprtumnité en paroimplantologie: Le PRF. Implantodontie 2001;42:55-62.
  • Dohan D, Donsimoni J-M, Navarro G, Gaultier F. Platelet concentrates, part II: associated biology. Implantodontie 2003;12:17-25.
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part I: technological concepts and and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):37-44. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part II: platelet related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e45-50.
  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e51-5.
  • Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e56-60.
  • Diss A, Dohan DM, Mouhyi J, Mahler P. Osteotome sinus flor elevation using Choukroun’s platelet-rich fibrin as grfting material: one year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105(5):572-9.
  • Choukroun JI, Braccini F, Diss A, Giordano G, Doglioli P, Dohan DM. Influence of plateler rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: a new opportunity in facial lipostructure (Coleman’s technique) and tympanoplasty? Rev Laryngol Otol Rhinol (Bord) 2007;128(1-2):27-32.
  • Braccini F, Dohan DM. The relevance of Choukroun’s plateler rich fibrin (PRF) during facial esthetic lipostructure (Coleman’s technique): preliminary results. Rev Laryngol Otol Rhinol(Bord) 2007;128(4):255-60.
  • Dohan DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol 2010;81(4):546-55.
  • Dohan DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27(1):63-9.
  • Cieslik-Bielecka A, Gazdzik TS, Bielecki TM, Cieslik T. Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Raidol Endod 2007;103(3):303-5.
  • El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 2007;78(4):661-9. van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis, Ann N Y Acad Sci 2001;936:426-37.
  • Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998;273(13):7554-9.
  • Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003;196(2):245-50.
  • Chang IC, Tsai CH, Chang YC. Plateletrich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res A 2010;95(1):327-32.
  • Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB. Choukroun’s Platelet-rich Fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependant way, Arch Oral Biol 2010;55(3):185-94.
  • Tsai CH, Shen SY, Zhao JH, Chang YC. Platelet-rich fibrin modulates cell proliferation of human periodontally related cells in vitro. J Dent Sci 2009;4:130-5. Tunalı M, Özdemir H, Küçükodacı Z, Akman S, Fıratlı E. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate. Br J Oral Maxillofac Surg 2013;51(5):438
  • Kim BJ, Kwon TK, Baek HS, Hwang DS, Kim CH, Chung IK, Jeong JS, Shin SH. A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and plateletrich-fibrin-mixed tricalcium phosphate in rabbits. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113(5):583-92.
  • Lee JW, Kim SG, Kim JY, Lee YC, Choi JY, Dragos R, Rotaru H. Restoration of a peri-implant defect by platelet-rich fibrin. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113(4):459-63.
  • Knapen M, Gheldof D, Drion P, Layrolle P, Rompen E, Lambert F. Effect of leukocyte- and platelet-rich fibrin (L-PRF) in bıne regeneration: a study in rabbits. Clin Implant Dent Relat Res 2013; doi: 1111/cid.12146. [Epub ahead of print]
  • Rudagi KB, Rudagi B. One-step apexification in ımmature tooth using grey mineral trioxide aggregate as an apical barrier and autologus platelet-rich fibrin membrane as an ınternal matrix. J Conserv Dent 2012;15(2):196-9.
  • Ruga E, Gallesio C, Boffano P. Plateletrich fibrin and piezoelectric surgery: a safe technique for the prevention of periodontal complications in third molar surgery. J Craniofac Surg 2011;22(5):1951-5.
  • Hoaglin DR, Lines GK. Prevention of localized osteitis in mandibular thirdmolar sites using platelet-rich fibrin. Int J Dent 2013; doi: 10.1155/2013/875380. Epub 2013 Apr 4.
  • Inchingolo F, Tatullo M, Marrelli M, Inchingolo AM, Scacco S, Inchingolo AD, Dipalma G, Vermesan D, Abbinante A, Cagiano R. Trial with platelet-rich fibrin and bio-oss used as grafting materials in the treatment of severe maxillar bone atrophy: clinical and radiological evaluations. Eur Rev Med Pharmacol Sci 2010;14(12):1075-84.
  • Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer DR, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using choukroun’s platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol 2009;80(12):2056-64.
  • Tajima N, Ohba S, Sawase T, Asahina I. Evaluation of sinus florr augmentation with simultaneous placement using platelet-rich fibrin as sole grafting material. Int J Oral Maxillofac Implants 2013;28(1):77-83.
  • Lekovic V, Milinkovic I, Aleksic Z, Jankovic S, Stankovic P, Kenney EB, Camargo PM. Platelet-rich fibrin and bovine porous bone mineral vs. plateletrich fibrin in the treatment of ıntrabony periodontal defects. J Periodontal Res 2012;47(4):409-17.
  • Bansal C, Bharti V. Evaluation of efficacy of autologous platelet-rich fibrin with demineralized-freeze dried bone allogaft in the treatment of periodontal intrabony defetcs. J Indian Soc Periodontol 2013;17(3):361-6.
  • Pradeep AR, Sharma A. Autologous platelet rich fibrin in the treatment of mandibular degree II furcation defects: a randomized clinical trial. J Periodontol 2011;82(10):1396-403.
  • Peck MT, Marnewick J, Stephen L. Alveolar ridge preservation using leukocyte and platelet-rich fibrin: a report of a case. Case Rep Dent 2011;345048.doi: 1155/2011/345048. Epub 2011 Jul 3. Hauser F, Gaydarov N, Badoud I, Vazquez L, Bernard JP, Ammann P. Clinical and histological evaluation of postextraction platelet-rich fibrin socket filling: a prospective randomized controlled study. Implant Dent 2013;22(3):295-303.
  • Del Corso M, Mazor Z, Rutkowski JL, Dohan Ehrenfest DM. The use of leukocyte- and platelet-rich fibrin during immediate postextractive implantation and loading for the esthetic replacement of a fractured maxillary central incisor. J Oral Implantol 2012;38(2):181-7.
  • Aroca S, Keglevich T, Nikolidakis D, Gera I, Nagy K, Azzi R, Etienne D. Treatment of class III multiple gingival recessions: a randomized-clinical trial. J Clin Periodontol 2010;37(1):88–97.
  • Jankovic S, Aleksic Z, Milinkovic I, Dimitrijevic B. The coronally advanced flap in combination with platelet-rich fibrin (PRF) and enamel matrix derivative in the treatment of gingival recession: a comparative study. Eur J Esthet Dent 2010;5(3):260-73.
  • Jankovic S, Aleksic Z, Klokkevold P, Lekovic V, Dimitrijevic B, Kenney EB, Camargo P. Use of platelet-rich fibrin membrane following treatment of gingival recession: a randomized clinical trial. Int J Periodontics Restorative Dent 2012;32(2):e41-50.
  • Eren G, Atilla G. Platelet-rich fibrin in the treatment of bilateral gingival recessions. Clinical Advances in Periodontics 2012;2(3):154-60.
  • Eren G. Kök yüzeyi örtülmesinde trombositten zengin fibrin ve bağ dokusu grefti uygulamalarının etkinliklerinin karşılaştırılması. Doktora Tezi, Ege Üniversitesi Sağlık Bilimleri Enstitüsü Periodontoloji Anabilim Dalı, 2012. Yazışma Adresi: Gülnihal EREN Ege Üniversitesi
  • Diş Hekimliği Fakültesi Periodontoloji A.D. 35100 Bornova-İzmir, Türkiye Tel: 0232 3881105 e-posta: gulnihal_karasu@hotmail.com
Toplam 50 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm Derlemeler / Reviews
Yazarlar

Gülnihal Eren Bu kişi benim

Gül Atilla Bu kişi benim

Yayımlanma Tarihi 27 Haziran 2014
Yayımlandığı Sayı Yıl 2014 Cilt: 48 Sayı: 2

Kaynak Göster

APA Eren, G., & Atilla, G. (2014). LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI. Journal of Istanbul University Faculty of Dentistry, 48(2), 73-83.
AMA Eren G, Atilla G. LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI. J Istanbul Univ Fac Dent. Haziran 2014;48(2):73-83.
Chicago Eren, Gülnihal, ve Gül Atilla. “LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI”. Journal of Istanbul University Faculty of Dentistry 48, sy. 2 (Haziran 2014): 73-83.
EndNote Eren G, Atilla G (01 Haziran 2014) LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI. Journal of Istanbul University Faculty of Dentistry 48 2 73–83.
IEEE G. Eren ve G. Atilla, “LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI”, J Istanbul Univ Fac Dent, c. 48, sy. 2, ss. 73–83, 2014.
ISNAD Eren, Gülnihal - Atilla, Gül. “LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI”. Journal of Istanbul University Faculty of Dentistry 48/2 (Haziran 2014), 73-83.
JAMA Eren G, Atilla G. LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI. J Istanbul Univ Fac Dent. 2014;48:73–83.
MLA Eren, Gülnihal ve Gül Atilla. “LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI”. Journal of Istanbul University Faculty of Dentistry, c. 48, sy. 2, 2014, ss. 73-83.
Vancouver Eren G, Atilla G. LÖKOSİT VE TROMBOSİTTEN ZENGİN FİBRİNİN ÖZELLİKLERİ VE DİŞ HEKİMLİĞİNDE KULLANIM ALANLARI. J Istanbul Univ Fac Dent. 2014;48(2):73-8.